SARS-CoV-2 virus-like particles (VLPs), which structurally mimic the native
virus, for antiviral and immunomodulatory effects in human induced pluripotent stem cell (iPSC)
[HTML][HTML] A decoy virus strategy using plant-produced SARS-CoV-2 virus-like-particles to inhibit infection and lung injury
Published: 06/15/2026